ACADIA Pharmaceuticals, Inc. (ACAD)
23.56
+0.10
(+0.43%)
USD |
NASDAQ |
Feb 06, 16:00
23.54
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 3.986B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 27.51M |
| Dynavax Technologies Corp. | 1.820B |
| Axsome Therapeutics, Inc. | 9.203B |
| Rhythm Pharmaceuticals, Inc. | 6.915B |
| Alnylam Pharmaceuticals, Inc. | 43.35B |
Market Cap Related Metrics
| PE Ratio | 15.16 |
| PS Ratio | 3.790 |
| PEG Ratio | 0.1498 |
| Price to Book Value | 4.345 |
| Price to Free Cash Flow | 40.09 |
| Price | 23.56 |
| Earnings Yield | 6.60% |
| PEGY Ratio | 0.1498 |
| Operating PE Ratio | 42.03 |
| Normalized PE Ratio | 15.16 |